Srirajaskanthan, R., Capdevila, J., Deshayes, E., Navalkissoor, S., Folitar, I., Lovelle, M., Delea, T., Gupta, S., Kumar, A., Pathak, P. (2025). Matching adjusted indirect comparison (MAIC) of 177 Lu-DOTATATE vs. sunitinib as first-line (1L) treatment for advanced grade 2 (G2) pancreatic neuroendocrine tumors (pNETs).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.664